Ok I dumped a huge parcel, , I believe// the selling in the States will be prolific and damning.
Top line data is what LCT are focused on, No Treatment for the Placebo Patients by order of the DSMB,
Still analysis to be done but would only trigger a new trial in a different direction, $5.5m on hand ,,,SH Know the burn rate..CR was on the cards , now will prove ridiculous and dilution will be ,,,well a lot.
Have enough to get me into the AGM,,, see you there.....
Ann: Results of LCT Parkinsons trial require further analysis, page-81
-
- There are more pages in this discussion • 83 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
